Company Update (NYSE:GE): General Electric Company to Sell Healthcare Financial Services U.S. Lending Business to Capital One

General Electric Company (NYSE:GE) announced that it has reached an agreement to sell $8.5 billion of healthcare-related loans and its Healthcare Financial Services (HFS) U.S. lending business to Capital One for approximately $9 billion. Separately, GE has signed an agreement with another buyer to sell approximately $600 million of HFS real estate equity investments.

“This transaction is another example of the value generated by GE Capital’s strong businesses and exceptional teams as we continue to demonstrate speed and execute on our strategy to sell most of the assets of GE Capital,” said Keith Sherin, GE Capital chairman and CEO. “We are on track to reduce our ending net investment (ENI) by $100 billion by the end of 2015 and expect to be substantially done with our exit strategy by the end of 2016,” he added.

GE Capital, Healthcare Financial Services provides financing to U.S. healthcare companies, sponsors, investors and developers across various healthcare sectors including senior housing, hospitals, medical offices, outpatient services, pharmaceuticals and medical devices. Darren Alcus, president and CEO of HFS, will join Capital One. Capital One also will retain the HFS management team and employees.

“We’re pleased to sell HFS to a company that is committed to expanding the business,” said Sherin. “Our customers, sponsors and HFS employees will benefit from the synergies of combining Capital One’s existing healthcare lending businesses with the expertise, relationships and experience of our highly-regarded HFS team.”

As previously announced, GE is embarking on a strategy to focus on its high-value industrial businesses and is selling most GE Capital assets. GE and its Board of Directors have determined that market conditions are favorable to pursue disposition of these assets.

GE Capital will retain the financing “verticals” that relate to GE’s industrial businesses, including a unit that provides healthcare equipment financing to GE Healthcare customers and others.

When completed, the transaction, which represents about $8.4 billion of ENI ($8.5 billion of assets), will contribute approximately $1.5 billion of capital to the overall target of approximately $35 billion of dividends expected to GE under this plan (subject to regulatory approval). GE is on track to reduce total ENI at GE Capital by about $100 billion by year end. With this transaction, the total for announced sales is approximately $78 billion.

Sherin concluded, “This announcement is the next step in GE’s transformation to a more focused industrial company.”

The transaction is subject to customary regulatory and other approvals and is expected to close in the fourth quarter of 2015. Citigroup Global Markets Inc. and J.P. Morgan Securities LLC provided financial advice to GE and Hogan Lovells US LLP provided legal advice. (Original Source)

Shares of General Electric closed today at $25.71, down $0.53 or 2.02%. GE has a 1-year high of $28.68 and a 1-year low of $23.41. The stock’s 50-day moving average is $26.49 and its 200-day moving average is $26.04.

On the ratings front, General Electric has been the subject of a number of recent research reports. In a report issued on July 20, UBS analyst Shannon O’Callaghan reiterated a Buy rating on GE, with a price target of $32, which implies an upside of 22.9% from current levels. Separately, on June 26, William Blair’s Nicholas Heymann reiterated a Hold rating on the stock and has a price target of $30.

According to, which ranks over 7,500 financial analysts and bloggers to gauge the performance of their past recommendations, Shannon O’Callaghan and Nicholas Heymann have a total average return of 17.0% and 2.3% respectively. O’Callaghan has a success rate of 79.5% and is ranked #144 out of 3729 analysts, while Heymann has a success rate of 44.4% and is ranked #2210.

Overall, 3 research analysts have assigned a Hold rating and 4 research analysts have given a Buy rating to the stock. When considering if perhaps the stock is under or overvalued, the average price target is $33.00 which is 26.8% above where the stock opened today.


Stay Ahead of Everyone Else

Get The Latest Stock News Alerts